A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment

BACKGROUND: Clozapine carries a US boxed warning for severe neutropenia, and strict monitoring is required through the FDA's Risk Evaluation and Mitigation Strategy (REMS) program. Patients with confirmed diagnosis of COVID-19 are also at risk for neutropenia. For patients on clozapine, the dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Denton, Lauren, Kapuganti, Amber, Kim, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583256/
https://www.ncbi.nlm.nih.gov/pubmed/37860587
http://dx.doi.org/10.9740/mhc.2023.08.190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583256/
https://www.ncbi.nlm.nih.gov/pubmed/37860587
http://dx.doi.org/10.9740/mhc.2023.08.190

Ejemplares similares